DOCC
Phase NA Completed
1,550 enrolled
Comparison of the Left-Lateral Horizontal and Supine Positions for Colonoscopy Intervention: A Randomized Controlled Study
Phase NA Completed
198 enrolled
DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer
Phase NA Completed
24 enrolled
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
Phase NA Completed
188 enrolled
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Phase 1/2 Completed
5 enrolled
COLOCROSS
Phase 3 Completed
89 enrolled
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Phase 2 Completed
24 enrolled 14 charts
00-046
Phase 3 Completed
4,952 enrolled
EHCancer
Phase NA Completed
212 enrolled
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Phase 1/2 Completed
23 enrolled
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer
Phase NA Completed
150 enrolled
Using Visual Arrays to Support Understanding of Genetic Risk
Phase NA Completed
1,045 enrolled
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
240 enrolled 14 charts
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Phase 2 Completed
42 enrolled 12 charts
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
Phase NA Completed
16 enrolled
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Phase NA Completed
231 enrolled
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Phase 1 Completed
52 enrolled
Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt
Phase NA Completed
150 enrolled
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
42 enrolled
PICoC
Phase 3 Completed
40 enrolled 19 charts
TAP
Phase NA Completed
200 enrolled 12 charts
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Phase 1 Completed
39 enrolled
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
Phase 1 Completed
15 enrolled
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
Phase NA Completed
46 enrolled 14 charts
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Phase 2 Completed
78 enrolled 14 charts
PeLear CCC
Phase NA Completed
60 enrolled 13 charts
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
83 enrolled 10 charts
MU-PRIOR
Phase NA Completed
116 enrolled
Edrecolomab in Treating Patients With Stage II Colon Cancer
Phase 3 Completed
2,100 enrolled
Efficacy and Safety of Supervised Therapeutic Exercise in Cancer Patients With and Without Concurrent Treatment.
Phase NA Completed
78 enrolled
Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the NYU FHCs
Phase NA Completed
1,283 enrolled
SUCCEED
Phase NA Completed
50 enrolled
Study of Colorectal Cancer Screening Options
Phase NA Completed
2,004 enrolled 8 charts
DA-CRC
Phase NA Completed
248 enrolled
NEFOPAM
Phase NA Completed
80 enrolled
QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Phase 1/2 Completed
43 enrolled 15 charts
High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Phase NA Completed
80 enrolled
MindCRC
Phase NA Completed
24 enrolled
Evaluation the of Role of Vitamin D Supplement on Tumor Response, Inflammation and Apoptosis in Patients With Stage II or III Colorectal Cancer Receiving Chemotherapy.
Phase 4 Completed
44 enrolled
IROCAS
Phase 3 Completed
792 enrolled
IMPACTT
Phase NA Completed
274 enrolled
AYAConnect
Phase NA Completed
63 enrolled
CALM: Managing Distress in Malignant Brain Cancer
Phase NA Completed
60 enrolled
NeoBRAF
Phase 2 Completed
2 enrolled
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
Phase NA Completed
508 enrolled 8 charts
RIFIONA
Phase 3 Completed
320 enrolled
Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
Phase 1/2 Completed
48 enrolled 16 charts
Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal Surgery
Phase NA Completed
98 enrolled 20 charts
AVR-CHEMO
Phase NA Completed
150 enrolled
FIDURA
Phase 3 Completed
354 enrolled